Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Revive Therapeutics Ltd

RVV
Current price
0.01 CAD 0 CAD (0.00%)
Last closed 0.01 CAD
ISIN CA7615161030
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Canadian Securities Exchange
Capitalization 3 589 381 CAD
Yield for 12 month -80.00 %
1Y
3Y
5Y
10Y
15Y
RVV
21.11.2021 - 28.11.2021

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada. Address: The Canadian Venture Building, Toronto, ON, Canada, M5C 1P1

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures RVV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 415 483 CAD
Operating Margin TTM
PE Ratio
Return On Assets TTM -14.75 %
PEG Ratio
Return On Equity TTM -39.01 %
Wall Street Target Price
Revenue TTM
Book Value 0.023 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.02 CAD
Diluted Eps TTM -0.02 CAD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics RVV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RVV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation RVV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.3919
Price Book MRQ 0.3651

Financials RVV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RVV

For 52 weeks

0.005 CAD 0.06 CAD
50 Day MA 0.013 CAD
Shares Short Prior Month 119 085
200 Day MA 0.025 CAD
Short Ratio 0.02
Shares Short 9 828
Short Percent 0.08 %